Cargando…
Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms
Fatigue, depression, and pain affect the majority of multiple sclerosis (MS) patients, which causes a substantial burden to patients and society. The pathophysiology of these symptoms is not entirely clear, and current treatments are only partially effective. Clinically, these symptoms share signs o...
Autores principales: | Heitmann, Henrik, Andlauer, Till F M, Korn, Thomas, Mühlau, Mark, Henningsen, Peter, Hemmer, Bernhard, Ploner, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131410/ https://www.ncbi.nlm.nih.gov/pubmed/33179588 http://dx.doi.org/10.1177/1352458520972279 |
Ejemplares similares
-
Resting-state EEG and MEG biomarkers of pathological fatigue – A transdiagnostic systematic review
por: Heitmann, Henrik, et al.
Publicado: (2023) -
Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers
por: Bussas, Matthias, et al.
Publicado: (2021) -
A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
por: Pulcu, Erdem, et al.
Publicado: (2021) -
What’s in a name? That which we call Multiple
Sclerosis Fatigue
por: Hubbard, Amy Lynn, et al.
Publicado: (2020) -
Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
por: Dormegny-Jeanjean, Ludovic Christophe, et al.
Publicado: (2023)